semaglutide being banned Novo Nordisk Urges FDA to Ban Compounded – What Weight-Loss Clinic Owners Need to Know FDA crackdown on off-brand Ozempic

Serious adverse events are less common but documented: pancreatitis, gallbladder disease, hypoglycemia (particularly in patients on concomitant diabetes medications), and a boxed warning regarding medullary thyroid carcinoma risk in rodent studies - a finding whose clinical significance in humans at therapeutic doses remains under study

This novel approach delivers unprecedented weight loss results, with Phase 2 trials showing an average of 24.2% body weight reduction at 48 weeks

N.SalinasG

If you notice symptoms returning before your next scheduled injection, contact your GP to discuss whether more frequent dosing is needed